Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.
Goldman L, Weinstein MC, Goldman PA, Williams LW. Goldman L, et al. Among authors: goldman pa. JAMA. 1991 Mar 6;265(9):1145-51. JAMA. 1991. PMID: 1899896
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. Gaspoz JM, et al. Among authors: goldman pa. N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309. N Engl J Med. 2002. PMID: 12050341 Free article.
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment.
Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC. Hunink MG, et al. Among authors: goldman l, goldman pa. JAMA. 1997 Feb 19;277(7):535-42. JAMA. 1997. PMID: 9032159
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease.
Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, Berenbaum PA, Goldman PA, Williams LW, Weinstein MC. Neumann PJ, et al. Among authors: goldman pa. Neurology. 1999 Apr 12;52(6):1138-45. doi: 10.1212/wnl.52.6.1138. Neurology. 1999. PMID: 10214734
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost.
Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, Weinstein MC. Goldman L, et al. Among authors: goldman pa. J Am Coll Cardiol. 2001 Oct;38(4):1012-7. doi: 10.1016/s0735-1097(01)01512-1. J Am Coll Cardiol. 2001. PMID: 11583874 Free article.
Health and economic benefits of increased beta-blocker use following myocardial infarction.
Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L. Phillips KA, et al. Among authors: goldman pa. JAMA. 2000 Dec 6;284(21):2748-54. doi: 10.1001/jama.284.21.2748. JAMA. 2000. PMID: 11105180
Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels.
Tosteson AN, Weinstein MC, Hunink MG, Mittleman MA, Williams LW, Goldman PA, Goldman L. Tosteson AN, et al. Among authors: goldman pa, goldman l. Circulation. 1997 Jan 7;95(1):24-30. doi: 10.1161/01.cir.95.1.24. Circulation. 1997. PMID: 8994412
Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications.
Goldman L, Goldman PA, Williams LW, Weinstein MC. Goldman L, et al. Among authors: goldman pa. Am J Cardiol. 1993 Sep 30;72(10):75D-79D. doi: 10.1016/0002-9149(93)90015-5. Am J Cardiol. 1993. PMID: 8213502
The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines.
Goldman L, Coxson P, Hunink MG, Goldman PA, Tosteson AN, Mittleman M, Williams L, Weinstein MC. Goldman L, et al. Among authors: goldman pa. J Am Coll Cardiol. 1999 Sep;34(3):768-76. doi: 10.1016/s0735-1097(99)00260-0. J Am Coll Cardiol. 1999. PMID: 10483959 Free article.
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.
Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Prosser LA, et al. Among authors: goldman pa. Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002. Ann Intern Med. 2000. PMID: 10819699
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback